PARIS :Paris prosecutors have opened a probe into Elon Musk's X social media over alleged algorithmic distortions, Franceinfo reports on Friday, citing the prosecutors' office. The investigation ...

Though their jewelry is mostly dainty, their high-shine finish makes them really stand out. Plus, I have a nickel allergy, which means that low-quality instantly gives me a rash. Every piece I've ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

Guidance for 2025 pointed to revenues growth at a high single-digit percentage and core earnings at a low double-digit, both at constant exchange rates. The shares rose 565.3p to 11,691.3p despite ...

Analysing the top 10 tech company logos, we can understand the art and science behind creating visual identities ... The sleek typography of the company name also conveys dynamism and movement, ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...

GSK today increased its 2031 sales outlook to more than £40 billion, up from £38 billion amid stronger progress in its late-stage drugs pipeline. Total 2024 sales in GSK’s annual results published ...

Q4 2024 dividend of 16p declared; 61p FY 2024; 64p expected for 2025. GSK (GSK) now intends to commence a GBP 2B share buyback programme, to be implemented over the next 18 months. Published first ...

GSK said it now e American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast.

Pharmaceuticals giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent ...

Pharmaceuticals giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent” ...